---

Related Articles:

Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical setting.

2014-12-01

[J. Am. Acad. Dermatol. 71(6) , 1167-75, (2014)]

Acitretin exhibits inhibitory effects towards UDP-glucuronosyltransferase (UGT)1A9-mediated 4-methylumbelliferone (4-MU) and propofol glucuronidation reaction.

2013-06-01

[Pharmazie 68(6) , 449-52, (2013)]

IgA pemphigus: case series with emphasis on therapeutic response.

2014-01-01

[J. Am. Acad. Dermatol. 70(1) , 200-1, (2014)]

Systemic retinoids in the management of ichthyoses and related skin types.

2013-01-01

[Dermatol. Ther. 26(1) , 26-38, (2013)]

From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies.

2014-01-01

[J. Am. Acad. Dermatol. 70(1) , 168-77, (2014)]